The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
Open accessAbstract
We previously reported encouraging results of down-staging of hepatocellular carcinoma (HCC) to meet conventional T2 criteria (one lesion 2–5 cm or two to three lesions <3 cm) for orthotopic liver transplantation (OLT) in 30 patients as a test of concept. In this ongoing prospective study, we analyzed longer-term outcome data on HCC down-staging in a larger cohort of 61 patients with tumor stage exceeding T2 criteria who were enrolled between June 2002 and January 2007. Eligibility criteria for down-staging included: (1) one lesion >5 cm and up to 8 cm; (2) two to three lesions with at least one lesion >3 cm and not exceeding 5 cm, with total tumor diameter up to 8 cm; or (3) four to five lesions with none >3 cm, with total tumor diameter up to 8 cm. A minimum observation period of 3 months after down-staging was required before OLT. Tumor down-staging was successful in 43 patients (70.5%). Thirty-five patients (57.4%) had received OLT, including two who had undergone live-donor liver transplantation. Treatment failure was observed in 18 patients (29.5%), primarily due to tumor progression. In the explant of 35 patients who underwent OLT, 13 had complete tumor necrosis, 17 met T2 criteria, and five exceeded T2 criteria. The Kaplan-Meier intention-to-treat survival at 1 and 4 years after down-staging were 87.5% and 69.3%, respectively. The 1-year and 4-year posttransplantation survival rates were 96.2% and 92.1%, respectively. No patient had HCC recurrence after a median posttransplantation follow-up of 25 months. The only factor predicting treatment failure was pretreatment alpha-fetoprotein >1,000 ng/mL. Conclusion: Successful down-staging of HCC can be achieved in the majority of carefully selected patients and is associated with excellent posttransplantation outcome. (Hepatology 2008.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Edmondson, H. A., & Steiner, P. E. (1954) · Cancer · doi:10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e · Cited by 2,772
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Self-citationLlovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients
Bismuth, H., Chiche, L., Adam, R., Castaing, D., Diamond, T., & Dennison, A. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00005 · Cited by 865
Yao, F. Y., Xiao, L., Bass, N. M., Kerlan, R., Ascher, N. L., & Roberts, J. P. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01965.x · Cited by 562
Self-citationMajno, P. E., Adam, R., Bismuth, H., Castaing, D., Ariche, A., Krissat, J., Perrin, H., & Azoulay, D. (1997) · Annals of Surgery · doi:10.1097/00000658-199712000-00006 · Cited by 513
Duffy, J. P., Vardanian, A., Benjamin, E., Watson, M., Farmer, D. G., Ghobrial, R. M., Lipshutz, G., Yersiz, H., Lu, D. S. K., Lassman, C., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318148c704 · Cited by 445
Otto, G., Herber, S., Heise, M., Lohse, A. W., Mönch, C., Bittinger, F., Hoppe-Lotichius, M., Schuchmann, M., Victor, A., & Pitton, M. (2006) · Liver Transplantation · doi:10.1002/lt.20837 · Cited by 410
Roayaie, S., Frischer, J. S., Emre, S. H., Fishbein, T. M., Sheiner, P. A., Sung, M., Miller, C. M., & Schwartz, M. E. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00012 · Cited by 390
Yao, F. Y., Bass, N. M., Nikolai, B., Davern, T. J., Kerlan, R., Wu, V., Ascher, N. L., & Roberts, J. P. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34923 · Cited by 389
Self-citationA prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
Yao, F. Y., Hirose, R., LaBerge, J. M., Davern, T. J., Bass, N. M., Kerlan, R. K., Merriman, R., Feng, S., Freise, C. E., Ascher, N. L., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20526 · Cited by 288
Self-citationLiver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
Wiesner, R. H., Freeman, R. B., & Mulligan, D. C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.040 · Cited by 273
Millonig, G., Graziadei, I. W., Freund, M. C., Jaschke, W. R., Stadlmann, S., Ladurner, R., Margreiter, R., & Vogel, W. (2007) · Liver Transplantation · doi:10.1002/lt.21033 · Cited by 257
Liver transplantation for hepatocellular carcinoma: The MELD impact
Sharma, P., Balan, V., Hernandez, J. L., Harper, A. M., Edwards, E. B., Rodriguez-Luna, H., Byrne, T., Vargas, H. E., Mulligan, D., Rakela, J., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20012 · Cited by 238
Maddala, Y. K., Stadheim, L., Andrews, J. C., Burgart, L. J., Rosen, C. B., Kremers, W. K., & Gores, G. (2004) · Liver Transplantation · doi:10.1002/lt.20099 · Cited by 214
Liver transplantation for hepatocellular carcinoma
Schwartz, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.041 · Cited by 189
Living donor liver transplantation for hepatocellular carcinoma
Kulik, L., & Abecassis, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.042 · Cited by 171
Yao, F. Y., Kinkhabwala, M., LaBerge, J. M., Bass, N. M., Brown, R., Kerlen, R., Venook, A., Ascher, N. L., Emond, J. C., & Roberts, J. P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00750.x · Cited by 170
Self-citationLiver Transplantation for Hepatocellular Carcinoma
Befeler, A. S., Hayashi, P. H., & Bisceglie, A. M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.033 · Cited by 132
Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision
Bruix, J., Fuster, J., & Llovet, J. M. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50124 · Cited by 106
Yao, F. Y. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-947295 · Cited by 37
Self-citationChao, S. D., Roberts, J. P., Farr, M., & Yao, F. Y. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01800.x · Cited by 26
Self-citation
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“In a landmarkmanuscript the so-called Milan criteria were established for patients with a single HCC 65 cmor up to three nodules63 cm [212].”
ResultInfluentialA global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Hepatocellular carcinoma: clinical frontiers and perspectives
Bruix, J., Gores, G. J., & Mazzaferro, V. (2014) · Gut · doi:10.1136/gutjnl-2013-306627 · Cited by 1,364
Metadata
- Authors
- Yao, F. Y., Kerlan, R. K., Hirose, R., Davern, T. J., Bass, N. M., Feng, S., Peters, M., Terrault, N., Freise, C. E., Ascher, N. L., & Roberts, J. P.
- Venue
- Hepatology
- Published
- 2008-09
- Volume
- 48
- Issue
- 3
- Pages
- 819-827
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2009988330
- Cited by
- 513
- References
- 24
- FWCI
- 24.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.